![Camilla MORGEN | Lead Epidemiologist for Obesity | Cand.Scient. San. Publ., PhD | Novo Nordisk, Copenhagen | Advanced Analytics-Real World Data and Epidemiology Camilla MORGEN | Lead Epidemiologist for Obesity | Cand.Scient. San. Publ., PhD | Novo Nordisk, Copenhagen | Advanced Analytics-Real World Data and Epidemiology](https://i1.rgstatic.net/ii/profile.image/599361423687682-1519910307446_Q512/Camilla-Morgen.jpg)
Camilla MORGEN | Lead Epidemiologist for Obesity | Cand.Scient. San. Publ., PhD | Novo Nordisk, Copenhagen | Advanced Analytics-Real World Data and Epidemiology
Melissa Tucker - Associate Manager, Compliance Auditing and Monitoring - Novo Nordisk Inc. | LinkedIn
![NOVO NORDISK A S General Corporate Statement By Foreign Issuer (Form6) (0001171843-20-001160) - Novo Nordisk (OTC:NONOF), Novo Nordisk (NYSE:NVO) - Benzinga NOVO NORDISK A S General Corporate Statement By Foreign Issuer (Form6) (0001171843-20-001160) - Novo Nordisk (OTC:NONOF), Novo Nordisk (NYSE:NVO) - Benzinga](https://www.sec.gov/Archives/edgar/data/353278/000117184320001160/f6k_26.jpg)
NOVO NORDISK A S General Corporate Statement By Foreign Issuer (Form6) (0001171843-20-001160) - Novo Nordisk (OTC:NONOF), Novo Nordisk (NYSE:NVO) - Benzinga
![NOVO NORDISK A S General Corporate Statement By Foreign Issuer (Form6) (0001171843-20-001160) - Novo Nordisk (OTC:NONOF), Novo Nordisk (NYSE:NVO) - Benzinga NOVO NORDISK A S General Corporate Statement By Foreign Issuer (Form6) (0001171843-20-001160) - Novo Nordisk (OTC:NONOF), Novo Nordisk (NYSE:NVO) - Benzinga](https://www.sec.gov/Archives/edgar/data/353278/000117184320001160/f6k_12.jpg)